The Last Human at the FDA: AI on a Skeleton Crew

{
  "id": "PP1162879",
  "track": "Health",
  "focus_area": null,
  "category": "Fireside Chat",
  "event_id": "PP1162879",
  "event_type": "panel",
  "format": "Fireside Chat",
  "genre": null,
  "subgenre": null,
  "name": "The Last Human at the FDA: AI on a Skeleton Crew",
  "presented_by": "Real Chemistry",
  "publish_at": "2026-02-03T15:22:00.000-06:00",
  "reservable": true,
  "reservable_id": "PP1162879",
  "reserved": false,
  "date": "2026-03-16",
  "end_time": "2026-03-16T11:00:00.000-05:00",
  "start_time": "2026-03-16T10:00:00.000-05:00",
  "message": null,
  "image": null,
  "credentials": [
    {
      "name": "Music Badge",
      "type": "music"
    },
    {
      "name": "Platinum Badge",
      "type": "platinum"
    },
    {
      "name": "Innovation Badge",
      "type": "innovation"
    },
    {
      "name": "Film & TV Badge",
      "type": "filmtv"
    }
  ],
  "contributors": [
    {
      "id": 98241,
      "company": "Arnall Golden Gregory LLP",
      "credential_types": [
        "filmtv",
        "innovation",
        "music"
      ],
      "entity_id": 2262450,
      "name": "Alan Minsk",
      "speaker_types": [
        "Speaker"
      ],
      "title": "Partner / Chair of the Food and Drug Practice / Co-chair of the Life Sciences industry team",
      "image": {
        "alt_text": "Alan Minsk",
        "credit": null,
        "url": "https://images.sxsw.com/TAjP9rr8ethz1BG_N4owogjAMjw=/600x600/images.sxsw.com/48/0c04052a-7cf6-c6c1-6ba2-b6fb08fa221f/pcid-1649347"
      },
      "speaker_type": "Speaker",
      "details": "Alan is a partner, chair of the Food & Drug practice, and\rco-chair of the Life Sciences industry team at Arnall\rGolden Gregory LLP.\rAlan is recognized by Chambers USA America’s\rLeading Lawyers for Life Sciences,\rRegulatory/Compliance and has been selected for\rinclusion in the International Who’s Who of Life\rSciences Lawyers from 2013-2025. Nominees are\rselected based upon comprehensive, independent\rsurvey work with both general counsel and private\rpractice lawyers worldwide. He serves as general\rcounsel of The Sharing Alliance Inc., a pharmaceutical\rtrade organization focused on compliance with the\rPrescription Drug Marketing Act and sample\raccountability.\rAlan focuses his practice on advising pharmaceutical,\rbiologic, medical device, cosmetic, and food (including\r\rdietary supplements and medical foods) companies on\rall legal and regulatory matters relating to the U.S. Food\rand Drug Administration. \rIn addition, Alan works with life science companies and\rventure capital firms on regulatory diligence matters\rinvolving acquisitions, divestitures, regulatory opinion\rletters, co-promotions, and licensing agreements. He\ralso drafts and reviews agreements relating to clinical\rtrials, quality, and contract manufacturing. He conducts\rin-house training on FDA and fraud and abuse topics.\rAlan has written book chapters, articles, and bulletins\ron a wide variety of issues, including 505(b)(2) NDAs,\rorphan drugs, product promotion, quality agreements,\rcompliance, and medical device regulation. He is the\reditor of AGG’s Food and Drug Newsletter. He has\rspoken throughout the U.S. and in Canada, Israel, and\rEurope.\rAlan currently serves on the advisory board of the Food\rand Law Drug Institute’s Food and Drug Journal.",
      "links": {},
      "type": "person"
    },
    {
      "id": 80051,
      "company": "Real Chemistry",
      "credential_types": [
        "filmtv",
        "innovation",
        "music"
      ],
      "entity_id": 2241357,
      "name": "Leslie Isenegger",
      "speaker_types": [
        "Speaker"
      ],
      "title": "Head, Client Development, RC Resolve",
      "image": {
        "alt_text": "Leslie Isenegger",
        "credit": null,
        "url": "https://images.sxsw.com/eB1G1kVmCp-2JGba_l-S3H62sKE=/65x197:978x1110/600x600/images.sxsw.com/48/69d4892a-c563-41bf-ac7d-8363e8a353e0/pcid-1630495"
      },
      "speaker_type": "Speaker",
      "details": "Leslie Isenegger brings two decades of communication experience specializing in the integration of corporate reputation and risk mitigation, public policy, and health economics. She builds communication platforms to establish corporate pricing principles, increase industry thought leadership, and prepare clients for pricing and market access challenges. Leslie has supported drug approvals, led coalition-building for health policy initiatives, and developed crisis communication protocols for healthcare companies.",
      "links": {},
      "type": "person"
    },
    {
      "id": 80049,
      "company": "PAREXEL",
      "credential_types": [
        "filmtv",
        "innovation",
        "music"
      ],
      "entity_id": 2241355,
      "name": "Tala Fakhouri",
      "speaker_types": [
        "Speaker"
      ],
      "title": "VP, Regulatory Consulting: AI & Digital Policy, Real-World Research",
      "image": {
        "alt_text": "Tala Fakhouri",
        "credit": null,
        "url": "https://images.sxsw.com/Q-Km0RF8fVZfaB9wroplIMAPj50=/600x600/images.sxsw.com/48/202ebc65-e2c6-61c0-20fe-472de5b16bef/pcid-1630494"
      },
      "speaker_type": "Speaker",
      "details": "Dr. Fakhouri is a strategic leader with extensive experience in regulatory affairs, AI-driven drug development, real-world data analytics and digital health technology. She has demonstrated success in developing and interpreting complex regulatory landscapes, providing strategic regulatory guidance, and fostering collaborations between regulators, industry and global stakeholders. Dr. Fakhouri has successfully led high-impact teams and managed complex initiatives to optimize regulatory decision-making and de-risk technology use in drug development. Formerly, Dr. Fakhouri was Associate Director for Data Science and Artificial Intelligence in the Office of Medical Policy, Center for Drug Evaluation and Research (CDER) at the FDA.",
      "links": {},
      "type": "person"
    }
  ],
  "venue": {
    "accessible": false,
    "age_policy": null,
    "floor": "2",
    "id": "V1703",
    "indoor_outdoor": "INDOOR",
    "mixhalo_url": null,
    "name": "Topaz Ballroom 1-3",
    "parent_id": "V1700",
    "parent_venue_name": "The LINE",
    "venue_entry_info": null,
    "formats": null,
    "location": {
      "address": "111 E Cesar Chavez St.",
      "lat_lon": [
        30.2626651,
        -97.7436224
      ],
      "city": "Austin",
      "postal_code": "78701",
      "state": "TX",
      "name": "The LINE"
    },
    "root": {
      "id": "V1700",
      "name": "The LINE",
      "mixhalo_url": null
    },
    "events": "[omitted 5 venue events]"
  },
  "description": "Historic workforce cuts at FDA, CDC, and NIH are gutting review desks and lab benches. Regulators now pin hopes on AI triage engines to keep drug approvals, inspections and outbreak models on track. With capacity math and pilot algorithms already in production, we'll discuss accountability when fewer humans oversee smarter tools. What’s the single most important question to tell if a regulatory AI is trustworthy or just a black box? Where do the FDA and CDC need outside expertise? How can orgs support, innovate or build partnerships without entanglement in ethical or bureaucratic red tape?",
  "experience_level": "Advanced",
  "audio_url": null,
  "accessibility": [
    "Closed captioned"
  ],
  "accessible_venue": false,
  "add_bcl_url": false,
  "add_slido": false,
  "after_midnight": null,
  "age_policy": null,
  "american_sign_language": false,
  "apple_url": null,
  "audio_description": false,
  "caption_url": null,
  "captioned_qa": false,
  "closed_captioned": true,
  "cpe_credit": false,
  "event_status": "none",
  "has_subtitles": false,
  "hash_tags": [],
  "high_sensory_experience": false,
  "live": false,
  "long_description": "Historic workforce cuts at FDA, CDC, and NIH are gutting review desks and lab benches. Regulators now pin hopes on AI triage engines to keep drug approvals, inspections and outbreak models on track. With capacity math and pilot algorithms already in production, we'll discuss accountability when fewer humans oversee smarter tools. What’s the single most important question to tell if a regulatory AI is trustworthy or just a black box? Where do the FDA and CDC need outside expertise? How can orgs support, innovate or build partnerships without entanglement in ethical or bureaucratic red tape?",
  "meeting_url": null,
  "meeting_url_live": false,
  "mentorly_url": null,
  "mobile_audio_url": null,
  "open_captioned": false,
  "playlist_tag": null,
  "rebroadcast": false,
  "recommended_ids": [],
  "search_conversions": null,
  "short_program": false,
  "slido_url": null,
  "sort": "LAST HUMAN AT THE FDA: AI ON A SKELETON CREW",
  "source": "Official",
  "squad_up_url": null,
  "stream_embed": null,
  "stream_id": null,
  "stream_url": null,
  "strobe_warning": false,
  "subdiscipline": null,
  "summit": null,
  "summit_display_name": null,
  "tags": [
    {
      "id": 2114,
      "name": "Ai",
      "created_at": "2020-01-17T14:51:44.091-06:00",
      "updated_at": "2026-02-18T15:48:17.273-06:00",
      "sort": "AI",
      "alpha": "A"
    },
    {
      "id": 1343,
      "name": "Technology",
      "created_at": "2017-10-11T17:42:23.253-05:00",
      "updated_at": "2024-09-13T07:02:24.613-05:00",
      "sort": "TECHNOLOGY",
      "alpha": "T"
    }
  ],
  "talent_attending": null,
  "title_only": false,
  "track_display_name": "Health",
  "trailer_id": null,
  "trailer_url": null,
  "video_on_demand": null,
  "vimeo_id": null,
  "vod": false,
  "xr_project_type": null,
  "youtube_id": null,
  "related_events": [],
  "related_sales_client": null
}